← 25 Aug 2026 · Short-term Top 10 — Health Care
Short-term Top 10 — Health Care — what changed on 26 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The short-term score is a published weighted sum of percentile ranks, rebalanced every Monday. A list is a published formula and its output, not a recommendation. Method version 3.
Get this list's changes every morning
One short email a day: who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. One email a day, unsubscribe in one click.
Membership
No company entered or left on 26 Aug 2026. The next scheduled change is at this list's next rebalance.
Inside the ten
Against the previous session, 25 Aug 2026.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| HINGE HEALTH INC CLASS A (HNGE) | 1 +1 | 71.6 −0.1 | Volume and participation 94th → 93rd |
| DEFINIUM THERAPEUTICS INC (DFTX) | 2 +2 | 71.1 +1.3 | Volume and participation 62nd → 77th |
| Merck & Co. (MRK) | 3 +37 | 70.9 +10.0 | Volume and participation 94th → 79th |
| Revolution Medicines (RVMD) | 4 +12 | 70.7 +5.3 | Volume and participation 53rd → 98th |
| GLAUKOS CORP (GKOS) | 5 −4 | 70.7 −1.0 | Volume and participation 76th → 63rd |
| Moderna (MRNA) | 10 −7 | 67.3 −3.0 | Volume and participation 83rd → 57th |
| KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) | 13 | 66.0 −0.1 | Momentum 55th → 58th |
| IMMUNOME INC (IMNM) | 18 −13 | 64.6 −5.0 | Volume and participation 50th → 21st |
| NUVATION BIO INC CLASS A (NUVB) | 38 −13 | 61.1 −2.6 | Setup 68th → 61st |
| ZENAS BIOPHARMA INC (ZBIO) | 44 +46 | 60.4 +5.7 | Catalysts 78th → 50th |
At the edge
Knocking
- LIFESTANCE HEALTH GROUP INC (LFST) scores 9.6 above the lowest member — the sector cap, not the score, is what is keeping it out
- Guardant Health, Inc. (GH) scores 9.4 above the lowest member — the sector cap, not the score, is what is keeping it out
Closest to the exit
- IMMUNOME INC (IMNM) 0.5 below the score at rank 15, where the hold band ends
- NUVATION BIO INC CLASS A (NUVB) 4.0 below the score at rank 15, where the hold band ends
- ZENAS BIOPHARMA INC (ZBIO) 4.7 below the score at rank 15, where the hold band ends
Ranked against 242 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
SPY is the S&P 500 ETF — the US large-cap market average.
−1.7% since the previous session (2026-08-25), against 0.0% for SPY — 1.7 points behind the benchmark. Tracked since 2026-08-18.
+2.1% since 2026-08-18, against −0.2% for SPY — 2.2 points ahead of the benchmark. Tracked since 2026-08-18.
Both curves are total return through 26 Aug 2026: a distribution buys more of the company that paid it, on the benchmark as much as on the list.
More
Informational only — NOT financial advice.